Effectiveness of interventions in pragmatic trials may not translate directly into population impact, because of limited uptake by clinicians and/or the public. Uptake of an intervention is influenced by a number of factors.
We propose a method for calculating population impact of clinical interventions that accounts for the intervention uptake. We suggest that population impact may be estimated by multiplying the two key components: (1) the effectiveness of the intervention in pragmatic trials (trial effect); and, (2) its uptake in clinical practice. We argue that participation rates in trials may be a valid proxy for uptake in clinical practice and, in combination with trial effectiveness estimates, be used to rank interventions by their likely population impact. We illustrate the method using the example of four interventions to decrease antibiotic prescription for acute respiratory infections in primary care: delayed prescribing, procalcitonin test, C-Reactive Protein, shared decision making.
In order to estimate uptake of interventions from trial data we need detailed reporting on the recruitment processes used for clinician participation in the trials. In the antibiotic prescribing example, between 75 and 91% of the population would still be prescribed or consume antibiotics because effective interventions were not taken up. Of the four interventions considered, we found that delayed prescribing would have the highest population impact and shared decision making the lowest.
Estimates of uptake and population impact of an intervention may be possible from pragmatic RCTs, provided the recruitment processes for these trials are adequately reported (which currently few of them are). Further validation of this method using empirical data on intervention uptake in the real world would support use of this method to decide on public funding of interventions.
Sackett DL. The Principles behind the tactics of performing therapeutic trials. In: Haynes RB, Sackett DL, Guyatt GH, Tugwell P, editors. Clinical epidemiology: how to do clinical practice research. Philadelphia: Lippincott, Williams and Wilkins; 2006. p. 183–8.
Dawson L, Zarin DA, Emanuel EJ, Friedman LM, Chaudhari B, Goodman SN. Considering Usual Medical Care in Clinical Trial Design. PLoS Med. 2009;6:e1000111. https://doi.org/10.1371/journal.pmed.1000111.
Zwarenstein M, Treweek S, Gagnier JJ, Altman DG, Tunis S, Haynes B, Oxman AD, Moher D. Improving the reporting of pragmatic trials: an extension of the CONSORT statement. BMJ. 2008;337:a2390.
Glasziou P, Haynes B. The paths from research to improved health outcomes. Evid Based Med. 2005;10:4–7. CrossRef
Grobbee EJ, van der Vlugt M, van Vuuren A, Stroobants AK, Mallant-Hent R, Lansdorp-Vogelaar I, Bossuyt P, Kuipers EJ, Dekker E, Spaander M. 176 comparison of colonoscopy. Sigmoidoscopy and Multiple Rounds of FIT-Based Colorectal Cancer Screening: Long-Term Follow-Up Gastroenterol. 2016;150:S45.
Review Manager (RevMan) [Computer program]. Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
SAS software, Version 9.4 of the SAS System for Unix. Copyright © 2002–2012 by SAS Institute Inc. SAS and all other SAS Institute Inc. product or service names are registered trademarks or trademarks of SAS Institute Inc., Cary, NC, USA.
Briel M, Langewitz W, Tschudi P, Young J, Hugenschmidt C, Bucher HC. Communication training and antibiotic use in acute respiratory tract infections. A cluster randomised controlled trial in general practice. Swiss Med Wkly. 2006;136:241–7. PubMed
Glasziou P, Altman DG, Bossuyt P, Boutron I, Clarke M, Julious S, Michie S, Moher D, Wager E: Reducing waste from incomplete or unusable reports of biomedical research. Lancet. 383:267–276.
Spurling GK, Del Mar CB, Dooley L, Foxlee R, Farley R: Delayed antibiotics for respiratory infections. Cochrane Database Syst Rev. 2013,4:Cd004417.
Schuetz P, Muller B, Christ-Crain M, Stolz D, Tamm M, Bouadma L, Luyt CE, Wolff M, Chastre J, Tubach F et al: Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. Cochrane Database Syst Rev. 2012,9:Cd007498.
Aabenhus R, Jensen JU, Jorgensen KJ, Hrobjartsson A, Bjerrum L. Biomarkers as point-of-care tests to guide prescription of antibiotics in patients with acute respiratory infections in primary care. Cochrane Database Syst Rev.. 2014,11:Cd010130.
Coxeter P, Del Mar CB, McGregor L, Beller EM, Hoffmann TC. Interventions to facilitate shared decision making to address antibiotic use for acute respiratory infections in primary care. Cochrane Database Syst Rev. 2015:CD010907.
- What’s the uptake? Pragmatic RCTs may be used to estimate uptake, and thereby population impact of interventions, but better reporting of trial recruitment processes is needed
Katy J. L. Bell
Chris Del Mar
- BioMed Central
Neu im Fachgebiet AINS
Meistgelesene Bücher aus dem Fachgebiet AINS
Mail Icon II